Edwards Lifesciences (EW) commented a federal jury’s decisions in patent litigation between Edwards and Boston Scientific (BSX): “The jury awarded $35M in damages to Boston Scientific for infringement of U.S. patent number 8,992,608 (the ‘608 patent) for a transcatheter heart valve sealing skirt. Edwards does not expect to pay the jury award since, earlier this year, the U.S. Patent and Trademark office determined that all asserted claims of the ‘608 patent were invalid. The jury found that Edwards’ foundational U.S. Spenser Patents for transcatheter heart valves are valid, but not infringed by the Lotus devices. Edwards plans to appeal. Boston Scientific initiated litigation that now involves multiple patents in multiple venues, and will likely yield court actions over an extended period of time.”
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.